ALC Stock Analysis: Buy, Sell, or Hold?

ALC - Alcon Inc. Ordinary Shares

Ophthalmic Goods
$80.98
-0.17 (-0.21%) β–Ό
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026 23d

Get Alerted When ALC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
βœ… BUY SIGNAL: ALC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$26.81
Based on -12.5% avg growth
INTRINSIC VALUE TODAY
$16.65
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ALC is currently trading at $80.98, which is considered slightly high relative to its 30-day fair value range of $79.25 to $81.10. The stock's valuation (Forward PE: 37.1) is in line with its historical norms (36.0). At these levels, the market is pricing in 1.0% annual earnings growth.

Technical Outlook: Technically, ALC is in a strong uptrend. The price is approaching resistance at $82.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ALC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $91.80 (+13.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $79.25 - $81.10
Company Quality Score 63/100 (BUY)
Volume Confirmation HIGH
Confidence Score 77.1%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($91.80)
  • BULLISH: Expecting earnings turnaround to 1.0% growth with 6.5% revenue growth

Fair Price Analysis

30-Day Fair Range $79.25 - $81.10
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $78.27
Resistance Level $82.14
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 37.10
Wall Street Target $91.80 (+13.1%)
Revenue Growth (YoY) 6.5%
Earnings Growth (YoY) -9.4%
Profit Margin 10.3%
Valuation Premium vs History +1.0% premium
PE vs Historical 37.1 vs 36.0 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.0% (market-implied from PE analysis)
1-Year Target $81.96 (+1%)
2-Year Target $82.78 (+2%)
3-Year Target $83.61 (+3%)
3-Yr Target (if PE normalizes) (PE: 37β†’36) PE COMPRESSION $81.13 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 37.1, Growth: -29.0%) $59.16 (+-27%)
Base: (SPY PE: 22.3, Growth: -29.0%) $35.56 (-56%)
Bear: (PE: 19.0, Growth: -29.0%) $30.23 (-63%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (37x PE) as earnings recover.
Trailing PE: 38.30 | Current EPS (TTM): $2.10
Bull Case $92.14 (+14%)
Analyst growth 4.2%, PE expands to 42.1
Base Case $83.77 (+3%)
Market implied 4.2%, PE stable at 38.3
Bear Case $54.69 (-33%)
Severe decline -20.0%, PE contracts to 32.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 5:47 AM ET
Data refreshes hourly during market hours. Next update: 6:47 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$608 58 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$191 58 HOLD
RMD
ResMed Inc
BUY
19 analysts
$292 57 HOLD
ALGN
Align Technology Inc
BUY
18 analysts
$184 62 BUY
COO
The Cooper Companies, Inc
BUY
19 analysts
$91 58 HOLD

Advanced ALC Option Strategies

Professional options setups generated by AI based on today's ALC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ALC

ALC Technical Chart ALC Price Prediction ALC Earnings Date ALC Investment Advisor ALC Fair Price Analyzer ALC Options Advisor ALC Options Chain ALC Options Analysis ALC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals